Three gastroenterologists spoke to Becker’s about trends they’re seeing in the industry — from declining reimbursement to competition with hospitals for talent. Allan Peck, MD, gastroenterology specialist in Montgomery, Ohio, told Becker’s he’s noticed a decline in compensation, particularly with hospital competition.
Author: Praveen Suthrum
Two weeks ago, Oshi Health raised $23 million from well-known investors. It reinforces the fact that the landscape of gastroenterology is shifting toward digitization.In this interview, Sam Holliday (CEO of Oshi Health) talks about their plans to scale across all 50 states by the end of 2022. They also plan to hire gastroenterologists and partner with GI practices. Learn about what’s attracting investor interest in digitization of gastroenterology.
In 2021, record levels of private investment will flow into the U.S. healthcare system accelerating merger and acquisition activity and fundamentally altering competition in the industry as organizations look beyond the pandemic.Financial sponsors i.e. private equity, hedge funds, large-cap multi-nationals operating in the U.S., ended 2020 with $2.9 trillion cash on hand to invest. Of more than 300 ‘blank check’ aka Special Purpose Acquisition Companies are looking for acquisitions–53 focused exclusively on healthcare deals. Last year, a record 7 unicorns ($1 billion in revenues and privately owned) went public with names like Oscar, 23 and Me, One Medical, GoodRx and…
Newsweek released its “World’s Best Specialized Hospitals 2021” list, ranking the best hospitals in the world. The publication partnered with Statista to determine the top 100 hospitals for gastroenterology, based on peer recommendations for areas of expertise. Out of the 50 facilities that were ranked on the list: 1. The U.S. has six facilities in the top 10. 2. The U.S. has 15 facilities, led by the Mayo Clinic in Rochester, Minn. The U.S. has the most facilities of any country included on the list.
Treatment with tofacitinib (Xeljanz) proved to be rapidly effective for moderate-to-severe ulcerative colitis (UC), even in patients who previously failed tumor necrosis factor (TNF) inhibition, post hoc analysis of trial data indicated. While the oral small-molecule JAK inhibitor had greater efficacy than placebo for both induction and maintenance of remission, rates of herpes zoster (serious and non-serious) were numerically higher in tofacitinib recipients, regardless of previous response to TNF inhibition, reported William Sandborn, MD, of the University of California San Diego.
Albert is Medical Director of Digestive Health at Advocate Illinois Masonic Medical Center and a member of the editorial board of Gastroenterology & Endoscopy News. Sharing brief safety stories at the beginning of our leadership meetings has been a great way to reinforce safety in patient care. The other day, I was asked to provide my own safety story: a story demonstrating a failure of sorts followed by a somewhat miraculous recovery where people come together in best practice to address it. Ultimately, the group will take a deep breath, sigh and reflect on the event. The team will regroup and…
Orlando (Fla.) Health and Titusville, Fla.-based Parrish Healthcare entered into a partnership to open an outpatient care center in Titusville, the Orlando Business Journal reported March 9. The clinic will be operated by Parrish Healthcare and staffed by Orlando Health specialists. Orlando Health will offer pediatric-focused gastroenterology, cardiology, endocrinology, urology, neurology and pulmonology services.
SAN ANTONIO – Many people have postponed all sorts of medical screenings during the COVID-19 pandemic. And while all medical tests are important, screening for colon cancer requires you to be thoughtful in how you do it. The wrong choice could add pain in the pocketbook or even potentially force you to miss a diagnosis. The choice between tests is wide, but some gastroenterologists want to make sure you know what you are signing up for medically as well as financially. As we mark Colon Cancer Awareness Month, you may be getting reminded it’s time to make that choice.
The American College of Gastroenterology updated its colorectal cancer screening guidance. The organization now recommends to begin screening average-risk men and women at 45 years. It was the top story in gastroenterology last week. Another top story explored how an intestinal infection with SARS-CoV-2 may affect disease pathogenesis. Researchers said the gut could have a role in attenuating inflammation associated with the virus.
Each year, Digestive Disease Week® (DDW) brings the gastrointestinal (GI) community together to exchange knowledge, formulate ideas and uncover new ways to improve the lives of those living with digestive diseases. Gastroenterologists, researchers, and other industry professionals gathered in San Diego and virtually for DDW2022® to share best practices, ground-breaking research, and industry expertise.